CD40 ligand (CD40L) delivers a contact-dependent signal to B cells which, in the presence of interleukin (IL)-4, drives immunoglobulin isotype switching to IgE. CD40L expression in T cells is transient, requires activation of protein kinase C and a rise in intracellular calcium concentration ([Ca 2+ ]i), and is inhibited by cyclosporin A (CsA). CsA also inhibited T-cell-dependent IL-4-driven IgE synthesis. We have found that expression of CD40L is developmentally regulated. Expression of CD40L was restricted to mature single-positive thymocytes which, in the presence of IL-4, were capable of inducing B cells to undergo IgE isotype switching. CD40L expression was severely decreased in cord blood lymphocytes and was associated with a severely decreased ability to undergo T-cell-dependent IgE isotype switching. Immunoglobulin isotype switching to IgE in human B cells requires interleukin (IL)-4 and a contact-dependent Tcell signal which is delivered by the CD40 ligand (CD40L) and which can be replaced by a CD40 monoclonal antibody (mAb) [1, 2]. IL-4 induces the transcription of a 1.8-kb ε germline mRNA which is not translated into a functional protein. Engagement of CD40 by its ligand or by mAb induces deletional switch recombination whereby the gene encoding the constant region of ε is juxtaposed to the rearranged variable region resulting in transcription of a mature 2.0-kb ε mRNA species. We examine the expression of CD40L in T cells by cell surface staining and by Northern blot analysis [3]. CD40L was not detectable in resting T cells but was expressed transiently in activated T cells. CD40L mRNA and cell surface expression peaked at 3 and 6 h, respectively, and were un-detectable 16 h after stimulation. Activation of protein ki-nase C (PKC) by phorbol myristate acetate (PMA) and increasing the intracellular calcium concentration by ionomy-cin were both required for CD40L expression. Next, we examined the effect of cyclosporin A (CsA), a naturally occurring
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